Prognostic method for the results of surgical treatment for morbid obesity during restrictive bariatric surgery
Abstract
The purpose of the work is to find an effective method for diagnosing the risks of relapse of obesity after bariatric surgery by measuring the level of ghrelin in the blood serum of patients with morbid obesity.
Material and methods. The results of changes in serum ghrelin levels in 23 patients with morbid obesity after bariatric surgery were analyzed.
Results. We found that there is an inverse correlative relationship between body mass index and the level of ghrelin in the blood. In case of weight loss and reduction of body weight, the secretion of ghrelin increases. And, conversely, its concentration decreases sharply with increasing body weight.
Conclusion. A favorable course of the postoperative period and minimal risks with a restrictive type of operation can be determined when the ghrelin level is 350 pkg/ml and more. If the concentration of this peptide hormone in the blood is less than 350 pkg/ml, there is a risk of relapse of obesity in the patient. In this case, bariatric surgery is supplemented with a bypass component.
About the Authors
O. V. GalimovRussian Federation
Ufa
V. O. Khanov
Russian Federation
Ufa
K. V. Nasyrova
Russian Federation
Ufa
D. O. Galimov
Russian Federation
Ufa
T. R. Ibragimov
Russian Federation
Ufa
References
1. Dedov I.I. [et al.] Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults). Obesity and metabolism. 2018;15(1):53-70. (In Russ.)
2. Coulman KD, Blazeby JM. Health-Related Quality of Life in Bariatric and Metabolic Surgery. Curr Obes Rep. 2020 Sep;9(3):307-314. (In Engl)
3. Anischenko VV, Semenov SA, Xalzov AV. The choice of type surgery at patients with obesity. Al’manakh Instituta khirurgii im. A.V. Vishnevskogo. 2012;7(1):130-131. (In Russ.).
4. Kermansaravi, M., Karami, R., Valizadeh, R. [et al.] Five-year outcomes of one anastomosis gastric bypass as conversional surgery following sleeve gastrectomy for weight loss failure. Sci Rep. 2022;12:10304 (In Engl). doi: 10.1038/s41598-022-14633-9
5. Galicia Ernst I, Torbahn G, Schwingshackl L, Knüttel H, Kob R, Kemmler W, Sieber CC, Batsis JA, Villareal DT, Stroebele-Benschop N, Visser M, Volkert D, Kiesswetter E, Schoene D. Outcomes addressed in randomized controlled lifestyle intervention trials in community-dwelling older people with (sarcopenic) obesity - An evidence map. Obes Rev. 2022 Oct;23(10):e13497. (In Engl)
6. Sposob vybora taktiki hirurgicheskogo lechenija bol'nyh s ozhireniem, associirovannym s saharnym diabetom 2 tipa, oslozhnjonnym sarkopeniej (The method of choosing the tactics of surgical treatment of patients with obesity associated with type 2 diabetes mellitus complicated by sarcopenia) : patent № 2748190 Ros. Federacija; zajavl. 11. 06. 2020; opubl. 20. 05. 2021. Bjulleten' № 14:14. (in Russ)
7. Nikonova LV, Davydchik EV. Ghrelin: physiological aspects of action. Journal of the Grodno State Medical University. 2013;(3):23-25. (In Russ).
8. Hiroshi Hosoda, Masayasu Kojima, Hisayuki Matsuo, Kenji Kangawa. Ghrelin and Des-acyl Ghrelin: Two Major Forms of Rat Ghrelin Peptide in Gastrointestinal Tissue. Biochemical and Biophysical Research Communications. 2000; 279(3):909-913. (in Engl)
9. Sposob prognozirovanija rezul'tatov hirurgicheskogo lechenija morbidnogo ozhirenija pri restriktivnom tipebariatricheskoj operacii (A method for predicting the results of surgical treatment of morbid obesity in restrictive type of bariatric surgery) : patent № 2 816 041 C1 Ros. Federacija; zajavl. 4. 09. 2023, opubl. 26. 03. 2024. Bjul. № 9:7. (In Russ.).
Review
For citations:
Galimov O.V., Khanov V.O., Nasyrova K.V., Galimov D.O., Ibragimov T.R. Prognostic method for the results of surgical treatment for morbid obesity during restrictive bariatric surgery. Bashkortostan Medical Journal. 2024;19(5):59-63. (In Russ.)